Stock listing
Passage Bio, Inc.
Selected listing: PASG · BOATS · USD · US
Passage Bio, Inc. (BOATS:PASG), Health Technology. Latest release Jun 25, 2026: Passage Bio and Remix Therapeutics Announce Merger Agreement.
- Ticker
- BOATS:PASG
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
About Passage Bio, Inc.
Passage Bio, Inc. is a public company traded under the ticker PASG in the American market. Passage Bio focuses on developing gene therapies for neurological diseases, aiming to address significant unmet medical needs in this area.
Latest news from Passage Bio, Inc.
Passage Bio and Remix Therapeutics Announce Merger Agreement
June 25, 2026
Passage Bio and Remix Therapeutics Announce Merger Agreement
June 23, 2026
Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates
April 20, 2026
Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights
March 3, 2026
Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights
November 10, 2025